About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD26.73
- USD27.13
- USD26.45
- USD46.00
- 9.10%
- 45M
- 58.68k
- 1.40M
- 1.6B
- 22.24
- -17.70%
Stock News
2 hours ago
Lululemon’s struggles mount, now with backlash against a new line of ‘see-through’ pants
MarketWatch
2 hours ago
The 10 best U.S. companies to work for in 2026, according to new Glassdoor report
CNBC
3 hours ago
Netflix's Warner Bros. acquisition may be a 'tough, long slog'
Yahoo
7 hours ago
High-Yield Credit Vs. Municipal Safety: Building An All-Terrain Income Portfolio
SeekingAlpha